CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise | +6,261 | 17,428 | ||
| 2026-02-28 | Gaines Scott Chief Customer Officer | Shares withheld for taxes | −2,580 | $7.61 | $20K | 14,848 |
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise · Restricted Stock Unit | −1,500 | 3,000 | ||
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise · Restricted Stock Unit | −604 | 2,414 | ||
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise · Restricted Stock Unit | −1,250 | 6,250 | ||
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise · Restricted Stock Unit | −1,657 | 9,936 | ||
| 2026-02-28 | Gaines Scott Chief Customer Officer | Option exercise · Restricted Stock Unit | −1,250 | 2,500 | ||
| 2026-02-27 | Gaines Scott Chief Customer Officer | Grant or award · Restricted Stock Unit | +32,218 | 32,218 | ||
| 2026-02-27 | Goldshleger Ilya Chief Operating Officer | Grant or award · Restricted Stock Unit | +32,218 | 32,218 | ||
| 2026-02-27 | Weinberg Eric See remarks | Grant or award · Restricted Stock Unit | +32,218 | 32,218 | ||
| 2026-02-27 | Kurtz Ronald M MD President & CEO | Grant or award · Restricted Stock Unit | +80,545 | 80,545 | ||
| 2026-01-12 | Wilterding Mark Chief Financial Officer | Grant or award · Stock Option (right to buy) | +258,770 | 258,770 | ||
| 2026-01-12 | Wilterding Mark Chief Financial Officer | Grant or award · Restricted Stock Unit | +163,528 | 163,528 | ||
| 2025-09-25 | Goldshleger Ilya See remarks | Option exercise | +15,096 | $4.34 | $66K | 57,342 |
| 2025-09-25 | Goldshleger Ilya See remarks | Option exercise | +8,349 | $4.13 | $34K | 65,691 |
| 2025-09-25 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) | −5,416 | 0 | ||
| 2025-09-25 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) | −9,680 | 0 | ||
| 2025-09-25 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) | −8,349 | 12,494 | ||
| 2025-07-31 | COHEN RAYMOND W Director | Grant or award | +35,668 | 35,668 | ||
| 2025-06-03 | LINK WILLIAM J PHD Director | Grant or award | +10,752 | 37,855 |
Page 4 of 15 · 300 trades